TY - JOUR
T1 - Preventive effect of a synthetic immunomodulator, 2-carboxyethylgermantum sesquioxide, on the generation of suppressor macrophages in mice immunized with allogeneic lymphocytes
AU - Kobayashi, Hiroyuki
AU - Aso, Hisashi
AU - Ishida, Nakao
AU - Maeda, Hiroshi
AU - Schmitt, David A.
AU - Pollard, Richard B.
AU - Suzuki, Fujio
PY - 1992
Y1 - 1992
N2 - The effect of 2-carboxyethylgermanium sesquioxide (Ge-132) on the generation of splenic suppressor macrophages (S-MØ in C3H/He mice (H-2k) immunized with allogeneic spleen cells from C57B1/6 mice (H-2b) was investigated. We have previously demonstrated that S-MØ expressing I-J antigen, which appeared during alloimmunization, inhibited cytotoxic T lymphocyte (CTL) generation in the MLR and the elimination of these S-MØ before subjection to the MLR resulted in more effective generation of CTL. The CTL activity, which was determined in vivo by the Winn's test, was markedly enhanced when immunized mice received a 100 mg/kg dose of Ge-132. The compound was found to be the most efficacious when injected simultaneously with the immunization. The activity of allospecific CTL co-cultured with MØ fractions obtained from immunized mice in a 4-h 51Cr-release assay was shown to be 31% lysis of the target cells as compared with 90% lysis of the target cells in effector cells co-cultured with normal MØ fractions. In contrast, effector cells co-cultured with MØ fractions from Ge-132-treated immunized mice lysed 95% of the target cells. Analysis of the level of I-J antigen expression on macrophages (MØ obtained from mice 7 days after immunization revealed a > 2.5-fold increase, whereas I-A antigen expression remained constant when compared with splenic MØ from naive mice. In contrast, the opposite effect on I-J and I-A antigen expression was observed in splenic MØ from alloimmunized mice treated with Ge-132. These results suggest that Ge-132 could regulate CTL generation in alloimmunized mice by preventing the generation of I-J+ S-MØ Ge-132: 2-carboxyethylgermanium sesquioxide
AB - The effect of 2-carboxyethylgermanium sesquioxide (Ge-132) on the generation of splenic suppressor macrophages (S-MØ in C3H/He mice (H-2k) immunized with allogeneic spleen cells from C57B1/6 mice (H-2b) was investigated. We have previously demonstrated that S-MØ expressing I-J antigen, which appeared during alloimmunization, inhibited cytotoxic T lymphocyte (CTL) generation in the MLR and the elimination of these S-MØ before subjection to the MLR resulted in more effective generation of CTL. The CTL activity, which was determined in vivo by the Winn's test, was markedly enhanced when immunized mice received a 100 mg/kg dose of Ge-132. The compound was found to be the most efficacious when injected simultaneously with the immunization. The activity of allospecific CTL co-cultured with MØ fractions obtained from immunized mice in a 4-h 51Cr-release assay was shown to be 31% lysis of the target cells as compared with 90% lysis of the target cells in effector cells co-cultured with normal MØ fractions. In contrast, effector cells co-cultured with MØ fractions from Ge-132-treated immunized mice lysed 95% of the target cells. Analysis of the level of I-J antigen expression on macrophages (MØ obtained from mice 7 days after immunization revealed a > 2.5-fold increase, whereas I-A antigen expression remained constant when compared with splenic MØ from naive mice. In contrast, the opposite effect on I-J and I-A antigen expression was observed in splenic MØ from alloimmunized mice treated with Ge-132. These results suggest that Ge-132 could regulate CTL generation in alloimmunized mice by preventing the generation of I-J+ S-MØ Ge-132: 2-carboxyethylgermanium sesquioxide
UR - http://www.scopus.com/inward/record.url?scp=0026678483&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026678483&partnerID=8YFLogxK
U2 - 10.3109/08923979209009238
DO - 10.3109/08923979209009238
M3 - Article
C2 - 1294625
AN - SCOPUS:0026678483
SN - 0892-3973
VL - 14
SP - 841
EP - 864
JO - Immunopharmacology and Immunotoxicology
JF - Immunopharmacology and Immunotoxicology
IS - 4
ER -